O-077 Gemcitabine/cisplatin plus bevacizumab or placebo in advanced malignant mesothelioma: A multi-center, double-blind placebo-controlled, randomized phase II trial
Kindler, H., Lu, C., Gandara, D., Stevenson, J., Krug, L., Janne, P., Gitlitz, B., Karrison, T., Stadler, W., Vokes, E.Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(05)80210-7
Date:
July, 2005
File:
PDF, 284 KB
english, 2005